It has been announced that G-ray Switzerland and CSEM have achieved a major milestone in packaging the latenium technology to deliver X-ray imaging solutions with the latenium Evaluation Kit. Centred on particle-counting X-ray imaging, these solutions are set to improve the quality of the images obtained from examinations such as breast cancer screening helping earlier detection and reducing the radiation doses currently needed for mammography.
Philippe Le Corre, CEO of G-ray Medical, stated: "This milestone enables us to demonstrate the huge potential of our latenium detectors with our first high resolution images."
G-ray Switzerland SA, a Neuchâtel start-up, is currently developing ultra-high performance detectors dedicated to medical applications (in particular mammography). These ultra-high performance detectors will be developed in partnership with CSEM, based on G-ray’s revolutionary latenium technology.
Mario El-Khoury, CEO at CSEM, added: "The main challenge is now miniaturising both the sensor's pixels and the system's energy consumption, whilst offering very high-quality X-ray imaging for new generations of medical imaging solutions.”
Since the beginning of the 21st century, there has been a worrying increase in cases of breast cancer among young women. To maximise the chances of recovery of this frequent cancer, an early and reliable diagnosis of the disease is crucial. G-Ray Medical intends to offer the medical world a new generation of X-ray imagers based on its latenium electronic technology. A specific development is on-going with CSEM G-ray to produce the first latenium-based medical detector, planned to be completed by end of 2019.